ID: ALA4212358

Max Phase: Preclinical

Molecular Formula: C29H32N4O3

Molecular Weight: 484.60

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H](NC(=O)c1ccc(CN2CCOCC2)cc1)c1ccc(NC(=O)[C@H]2C[C@@H]2c2cccnc2)cc1

Standard InChI:  InChI=1S/C29H32N4O3/c1-20(31-28(34)23-6-4-21(5-7-23)19-33-13-15-36-16-14-33)22-8-10-25(11-9-22)32-29(35)27-17-26(27)24-3-2-12-30-18-24/h2-12,18,20,26-27H,13-17,19H2,1H3,(H,31,34)(H,32,35)/t20-,26+,27-/m0/s1

Standard InChI Key:  AWXZUTOSDKWFDE-BAURHKQJSA-N

Associated Targets(Human)

A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
COR-L23 (253 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 484.60Molecular Weight (Monoisotopic): 484.2474AlogP: 4.15#Rotatable Bonds: 8
Polar Surface Area: 83.56Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.96CX Basic pKa: 6.66CX LogP: 3.13CX LogD: 3.06
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.50Np Likeness Score: -1.59

References

1. Palacios DS, Meredith E, Kawanami T, Adams C, Chen X, Darsigny V, Geno E, Palermo M, Baird D, Boynton G, Busby SA, George EL, Guy C, Hewett J, Tierney L, Thigale S, Weihofen W, Wang L, White N, Yin M, Argikar UA..  (2018)  Structure based design of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors from a phenotypic screen.,  28  (3): [PMID:29275937] [10.1016/j.bmcl.2017.12.037]

Source